登录/ 注册

Novo Nordisk will slash US list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 35% and 50% respectively starting next year, said the Danish drugmaker. READ MORE

02-25 01:15
利好
利空

热门资讯